Home
Nektar Therapeutics

Nektar Therapeutics Market Share Analysis for May 2026

Explore biotechnology careers at Nektar Therapeutics. Join our innovative team developing life-changing therapies.

Health > Biotechnology and Pharmaceuticals

Domainnektar.com

Year Founded1990

Employees51 - 200

Annual Revenue$100M - $200M

Nektar Therapeutics

Nektar Therapeutics (including company regionals)

nektar.com

See more website traffic and engagement information

Nektar Therapeutics Revenue up to May 2026 is 100M - 200M

revenue generated by Nektar Therapeutics top domains

Nektar Therapeutics top domains revenue over 3 years

Revenue for Nektar Therapeutics top domains

nektar.com100M - 200M

See more with Sales Intelligence

Total visits to Nektar Therapeutics's top domains

Understand Nektar Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nektar.com35.1K

See more with Sales Intelligence

Avg. visit duration in Nektar Therapeutics's top domains

Analyze Nektar Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nektar.com00:00:18

See more with Sales Intelligence

Avg. pageviews on Nektar Therapeutics's top domains

See how Nektar Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nektar.com1.70

See more with Sales Intelligence

Nektar Therapeutics top competitors by domain

Top similar sites in May 2026, ranked by their affinity

biomarin.comCompany NameBioMarinEmployees1001 - 5000HQUnited States, California, San RafaelAnnual revenue> $1BTotal visits109.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Nektar Therapeutics

These are the website technologies, by industry, used by Nektar Therapeutics top domains

Widget (6)

Twemoji

Advertising (4)

DoubleClick

Audio Video Media (3)

Vimeo

Conversion & Analytics (3)

Google Analytics

More Technologies

10

See all

News & Signals from Nektar Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNektar Therapeutics attended event 2026 Jefferies Global Healthcare Conference on Jun 3rd '26.SAN FRANCISCO, May 27, 2026 /PRNewswire/ - Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the 2026 Jefferies Global Healthcare Conference being held June 2-4, 2026 in New York.

NewsNektar Therapeutics has issues with securities fraud lawsuit.NKTR deadline: NKTR investors have opportunity to lead Nektar Therapeutics securities fraud lawsuit.

NewsNektar Therapeutics received financing of $250M in underwritten public offering on Apr 20th '26.San Francisco-based Nektar Therapeutics (Nasdaq: NKTR) announced on April 20, 2026, an underwritten public offering of USD 250 million in common stock and pre-funded warrants, with proceeds directed toward funding Phase III clinical trials for its lead asset rezpegaldesleukin in atopic dermatitis and alopecia areata, as well as broader research, development, and manufacturing costs.